Masimo ROE 2007-2018 | MASI

Current and historical return on equity (ROE) values for Masimo (MASI) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Masimo ROE for the three months ending September 30, 2018 was 20.29%.
Masimo ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-09-30 $0.15B $0.91B 18.09%
2018-06-30 $0.13B $0.83B 16.49%
2018-03-31 $0.13B $0.77B 17.28%
2017-12-31 $0.13B $0.72B 18.97%
2017-09-30 $0.35B $0.72B 53.13%
2017-06-30 $0.34B $0.71B 60.82%
2017-03-31 $0.33B $0.63B 71.35%
2016-12-31 $0.30B $0.56B 82.69%
2016-09-30 $0.11B $0.33B 37.54%
2016-06-30 $0.10B $0.30B 36.50%
2016-03-31 $0.09B $0.27B 32.85%
2015-12-31 $0.08B $0.28B 28.79%
2015-09-30 $0.08B $0.27B 27.00%
2015-06-30 $0.08B $0.28B 25.31%
2015-03-31 $0.07B $0.33B 22.98%
2014-12-31 $0.07B $0.31B 23.10%
2014-09-30 $0.06B $0.28B 19.03%
2014-06-30 $0.06B $0.32B 18.90%
2014-03-31 $0.07B $0.35B 20.22%
2013-12-31 $0.06B $0.33B 19.11%
2013-09-30 $0.06B $0.31B 21.99%
2013-06-30 $0.06B $0.29B 21.31%
2013-03-31 $0.06B $0.28B 21.61%
2012-12-31 $0.06B $0.28B 21.67%
2012-09-30 $0.06B $0.31B 21.25%
2012-06-30 $0.06B $0.30B 21.91%
2012-03-31 $0.06B $0.28B 21.87%
2011-12-31 $0.06B $0.28B 23.04%
2011-09-30 $0.07B $0.30B 24.88%
2011-06-30 $0.07B $0.28B 26.51%
2011-03-31 $0.06B $0.26B 26.69%
2010-12-31 $0.07B $0.23B 31.98%
2010-09-30 $0.07B $0.25B 29.19%
2010-06-30 $0.07B $0.23B 27.28%
2010-03-31 $0.07B $0.21B 26.17%
2009-12-31 $0.05B $0.29B 20.17%
2009-09-30 $0.04B $0.27B 15.51%
2009-06-30 $0.04B $0.25B 16.47%
2009-03-31 $0.04B $0.24B 16.78%
2008-12-31 $0.03B $0.22B 16.20%
2008-09-30 $0.04B $0.21B 24.41%
2008-06-30 $0.04B $0.19B 23.60%
2008-03-31 $0.03B $0.17B 22.56%
2007-12-31 $0.02B $0.15B 25.27%
2007-09-30 $0.02B $0.14B 28.04%
2007-06-30 $0.01B $0.08B 62.34%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $5.811B $0.798B
Masimo Corporation is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. They believe that Masimo SET helps clinicians monitor in excess of approximately million patients in healthcare settings around the world, and is the pulse oximeter technology used by the top hospitals. Masimo as a private `garage start-up` company because they convinced that the use of adaptive signal processing in the measurement of physiological parameters could solve the problems of low perfusion and motion, which had long plagued in-vivo monitoring and especially pulse oximetry, the measurement of the oxygen saturation of arterial blood. His solution, Masimo SET Measure-through Motion and Low Perfusion pulse oximetry, was shown in a study comparing three pulse oximetry technologies to demonstrate the highest sensitivity and specificity in identifying desaturation events during conditions of motion and low perfusion.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $97.045B 22.61
Intuitive Surgical (ISRG) United States $59.217B 58.26
Edwards Lifesciences (EW) United States $32.551B 34.83
Fresenius Medical Care AG KGaA (FMS) Germany $24.608B 16.66
IDEXX Laboratories (IDXX) United States $17.365B 49.60
ABIOMED (ABMD) United States $14.403B 103.49
DexCom (DXCM) United States $12.274B 0.00
Teleflex (TFX) United States $12.055B 27.37
Hologic (HOLX) United States $11.459B 18.80
Varian Medical Systems (VAR) United States $10.872B 26.93
STERIS (STE) United Kingdom $10.002B 26.54
LivaNova (LIVN) United Kingdom $6.106B 39.19
Globus Medical (GMED) United States $5.097B 31.95
Penumbra (PEN) United States $4.712B 284.52
Integra LifeSciences Holdings (IART) United States $4.624B 22.52
Wright Medical Group (WMGI) Netherlands $3.695B 0.00
Cantel Medical (CMD) United States $3.586B 36.13
Inogen (INGN) United States $3.026B 65.32
Integer Holdings (ITGR) United States $2.776B 23.23
Halyard Health (AVNS) United States $2.304B 20.76
Glaukos (GKOS) United States $2.142B 0.00
OPKO Health (OPK) United States $1.993B 0.00
Tandem Diabetes Care (TNDM) United States $1.921B 0.00
Mazor Robotics (MZOR) Israel $1.535B 0.00
AxoGen (AXGN) United States $1.225B 0.00
Nevro (NVRO) United States $1.217B 0.00
Luminex (LMNX) United States $1.204B 43.56
Natus Medical (BABY) United States $1.146B 24.06
Pacific Biosciences Of California (PACB) United States $1.123B 0.00
Orthofix (OFIX) United States $1.108B 32.01
CryoLife (CRY) United States $1.094B 95.93
Tactile Systems Technology (TCMD) United States $1.081B 172.12
Intersect ENT (XENT) United States $0.952B 0.00
AngioDynamics (ANGO) United States $0.806B 28.19
Accelerate Diagnostics (AXDX) United States $0.782B 0.00
Mesa Laboratories (MLAB) United States $0.768B 45.43
ViewRay (VRAY) United States $0.663B 0.00
Veracyte (VCYT) United States $0.562B 0.00
Sientra (SIEN) United States $0.522B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.419B 0.00
Accuray (ARAY) United States $0.408B 0.00
SI-BONE INC (SIBN) United States $0.407B 0.00
Quotient (QTNT) Switzerland $0.374B 0.00
OrthoPediatrics (KIDS) United States $0.365B 0.00
Nuvectra (NVTR) United States $0.325B 0.00
Fluidigm (FLDM) United States $0.322B 0.00
Neuronetics (STIM) United States $0.318B 0.00
IRadimed (IRMD) United States $0.299B 78.06
SeaSpine Holdings (SPNE) United States $0.285B 0.00
GenMark Diagnostics (GNMK) United States $0.280B 0.00
RTI Surgical (RTIX) United States $0.278B 43.80
Pulse Biosciences (PLSE) United States $0.215B 0.00
T2 Biosystems (TTOO) United States $0.204B 0.00
Helius Medical Technologies (HSDT) United States $0.189B 0.00
Ekso Bionics Holdings (EKSO) United States $0.127B 0.00
Alphatec Holdings (ATEC) United States $0.123B 0.00
Ra Medical Systems (RMED) United States $0.103B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.098B 0.00
Sensus Healthcare (SRTS) United States $0.094B 0.00
Second Sight Medical Products (EYES) United States $0.090B 0.00
Apollo Endosurgery (APEN) United States $0.077B 0.00
EDAP TMS (EDAP) France $0.076B 0.00
Restoration Robotics (HAIR) United States $0.072B 0.00
Viveve Medical (VIVE) United States $0.068B 0.00
Biosig Technologies (BSGM) United States $0.066B 0.00
OBALON THERPTCS (OBLN) United States $0.046B 0.00
Vermillion (VRML) United States $0.038B 0.00
ConforMIS (CFMS) United States $0.033B 0.00
Lianluo Smart (LLIT) China $0.028B 0.00
Neovasc (NVCN) Canada $0.027B 0.00
PAVmed (PAVM) United States $0.027B 0.00
Titan Medical (TMDI) Canada $0.027B 0.00
ENDRA Life Sciences (NDRA) United States $0.022B 0.00
DarioHealth (DRIO) Israel $0.021B 0.00
Dynatronics (DYNT) United States $0.021B 0.00
Nanovibronix (NAOV) United States $0.015B 0.00
Bioanalytical Systems (BASI) United States $0.015B 0.00
Presbia (LENS) Ireland $0.012B 0.00
Microbot Medical (MBOT) United States $0.010B 0.00
ReWalk Robotics (RWLK) Israel $0.009B 0.00
Allied Healthcare Products (AHPI) United States $0.008B 0.00
Sunshine Heart Inc (CHFS) United States $0.007B 0.00
Atossa Genetics (ATOS) United States $0.007B 0.00
Cesca Therapeutics (KOOL) United States $0.007B 0.00
Avinger (AVGR) United States $0.003B 0.00
Amedica (SINT) United States $0.003B 0.00
EnteroMedics (RSLS) United States $0.000B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00